Estudos in vitro e in vivo de Annona muricata L. contra uma linhagem de Candida albicans multirresistente: atividade do extrato livre e incorporado a uma formulação a base de carbopol
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Bioactive natural products have stood out as sources of chemical diversity in the search
for strategies for the discovery of new drugs. In this scenario, Annona muricata
L. is traditionally used in the treatment of inflammatory, infectious and cancer diseases.
However, its antifungal potential, as well as its mechanism of action, still needs further
studies. The objective of this work was to evaluate the antifungal activity of the
ethanolic extract of the leaves of A. muricata against a multidrug-resistant strain of
Candida albicans (ATCC® 10231) and to develop a carbopol-based formulation
containing the extract, aiming at the treatment of vulvovaginal candidiasis (VVC).
Studies in planktonic cells were evaluated by the growth curve, cell density,
mechanism of action in cell envelope and mitochondrial membrane potential. Analysis
of the composition of the extracellular polymeric matrix. The in vivo assays comprised
experimental VVC models testing, in addition to A. muricata, its form incorporated into
carbopol. Our analyzes indicated a promising inhibitory effect of A. muricata, with the
ability to reduce fungal growth, as well as the number of cells. In view of the cell
envelope studies, the extract affected both the fungal membrane and the integrity of
the cell wall, altering viability. Mitochondrial membrane depolarization was indicated
after treatment with A. muricata. Regarding the bifilm assays, a reduction in
proliferation, adhesion and polymeric matrix of C. albicans was observed. The in vivo
assays demonstrated that A. muricata free and incorporated into the gel were able to
reduce the fungal load, the inflammatory process and, in the presence of carbopol, an
increase in mucoadhesiveness. Thus, A. muricata has antifungal potential in the
treatment of C. albicans infections and the carbopol-based formulation showed the
ability to be used in dermatological applications, providing its future use for the
treatment of VVC. New product improvement studies will still be carried out, being
necessary for a better understanding of its mechanism and physical-chemical
characteristics.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

